By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Proteon Therapeutics, Inc. 

4420 Madison Avenue
Suite 180
Kansas City  Missouri  64111  U.S.A.
Phone: 816-531-0028 Fax: 816-531-3079


SEARCH JOBS


Industry
Biotechnology






Company News
Proteon (PRTO) Announces Publication In The Journal Of Cardiovascular Pharmacology Of Promising Nonclinical Results For Vonapanitase In Peripheral Artery Disease 4/13/2016 7:56:37 AM
Proteon Therapeutics, Inc. (PRTO) To Present At The 2016 BIO CEO & Investor Conference February 8th 2/2/2016 8:10:27 AM
Proteon Therapeutics, Inc. (PRTO) To Present At The Oppenheimer 26th Annual Healthcare Conference December 9th 12/2/2015 8:20:14 AM
Proteon Therapeutics, Inc. (PRTO) To Present At The Stifel 2015 Healthcare Conference On November 17th 11/13/2015 10:10:01 AM
Proteon Therapeutics, Inc. (PRTO) Announces Third Quarter 2015 Financial Results 11/12/2015 7:31:19 AM
Proteon Therapeutics, Inc. (PRTO) To Host Research And Development Day On November 20, 2015 11/9/2015 10:10:21 AM
Proteon Therapeutics, Inc. (PRTO) Completes Enrollment In PATENCY-1, First Phase III Clinical Study Of Investigational Vonapanitase 11/3/2015 7:37:25 AM
Proteon Therapeutics, Inc. (PRTO) To Present At The BIO-Europe 2015 Conference November 3 10/29/2015 10:47:10 AM
Proteon Therapeutics, Inc. (PRTO) Appoints Tony Kingsley To Its Board Of Directors 10/19/2015 7:37:56 AM
Proteon Therapeutics, Inc. (PRTO) Announces Results From Phase I Study Of Investigational Drug Vonapanitase In Patients With Symptomatic Peripheral Artery Disease Presented At TCT 2015 10/12/2015 7:15:22 AM
123456
//-->